

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.89013544 |
| 2 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.29889724 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17486599 |
| 4 | nuclear pore organization (GO:0006999) | 3.91233079 |
| 5 | embryonic process involved in female pregnancy (GO:0060136) | 3.77204522 |
| 6 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.76356568 |
| 7 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67346800 |
| 8 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.65980167 |
| 9 | negative regulation of B cell mediated immunity (GO:0002713) | 3.65980167 |
| 10 | cellular response to ethanol (GO:0071361) | 3.62223910 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.54242740 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54242740 |
| 13 | regulation of RNA export from nucleus (GO:0046831) | 3.54229629 |
| 14 | pore complex assembly (GO:0046931) | 3.47209677 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.40957791 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39988366 |
| 17 | definitive hemopoiesis (GO:0060216) | 3.36710383 |
| 18 | histone H3-K36 demethylation (GO:0070544) | 3.34958625 |
| 19 | negative T cell selection (GO:0043383) | 3.34296100 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.31498369 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26353202 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24305557 |
| 23 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.22191545 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 3.17112613 |
| 25 | dosage compensation (GO:0007549) | 3.16710164 |
| 26 | germinal center formation (GO:0002467) | 3.15673043 |
| 27 | regulation of histone H3-K27 methylation (GO:0061085) | 3.13871411 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.09115935 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05836951 |
| 30 | histone lysine demethylation (GO:0070076) | 3.05783349 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04398399 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.03230692 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97368342 |
| 34 | COPI coating of Golgi vesicle (GO:0048205) | 2.96738037 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 2.96738037 |
| 36 | negative regulation of humoral immune response (GO:0002921) | 2.94010386 |
| 37 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.92708742 |
| 38 | hypotonic response (GO:0006971) | 2.91236032 |
| 39 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.88491532 |
| 40 | histone H3-K9 demethylation (GO:0033169) | 2.86882383 |
| 41 | histone demethylation (GO:0016577) | 2.84970678 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 2.79820152 |
| 43 | regulation of necroptotic process (GO:0060544) | 2.78393879 |
| 44 | positive T cell selection (GO:0043368) | 2.77708811 |
| 45 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76592363 |
| 46 | protein localization to endosome (GO:0036010) | 2.75776110 |
| 47 | T cell selection (GO:0045058) | 2.71698548 |
| 48 | tachykinin receptor signaling pathway (GO:0007217) | 2.68491170 |
| 49 | negative regulation of adaptive immune response (GO:0002820) | 2.68413711 |
| 50 | iron ion import (GO:0097286) | 2.66085636 |
| 51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63506095 |
| 52 | response to interleukin-15 (GO:0070672) | 2.63421567 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63272361 |
| 54 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63272361 |
| 55 | COPII vesicle coating (GO:0048208) | 2.59475731 |
| 56 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56745506 |
| 57 | protein demethylation (GO:0006482) | 2.54614272 |
| 58 | protein dealkylation (GO:0008214) | 2.54614272 |
| 59 | mitotic sister chromatid cohesion (GO:0007064) | 2.53772646 |
| 60 | protein targeting to Golgi (GO:0000042) | 2.53640723 |
| 61 | negative regulation of complement activation (GO:0045916) | 2.53563578 |
| 62 | negative regulation of type 2 immune response (GO:0002829) | 2.53333465 |
| 63 | establishment of protein localization to Golgi (GO:0072600) | 2.52579313 |
| 64 | positive regulation of tolerance induction (GO:0002645) | 2.51391564 |
| 65 | nerve growth factor signaling pathway (GO:0038180) | 2.48547177 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48188485 |
| 67 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.46834563 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 2.46172099 |
| 69 | response to nerve growth factor (GO:1990089) | 2.45347386 |
| 70 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.45347386 |
| 71 | tolerance induction (GO:0002507) | 2.44906785 |
| 72 | peptidyl-threonine modification (GO:0018210) | 2.41149291 |
| 73 | activated T cell proliferation (GO:0050798) | 2.39444578 |
| 74 | regulation of granulocyte differentiation (GO:0030852) | 2.37379790 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.37104296 |
| 76 | phospholipid translocation (GO:0045332) | 2.36928462 |
| 77 | lipid translocation (GO:0034204) | 2.36928462 |
| 78 | axonemal dynein complex assembly (GO:0070286) | 2.35255693 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.35196685 |
| 80 | peptidyl-threonine phosphorylation (GO:0018107) | 2.32575672 |
| 81 | regulation of establishment of cell polarity (GO:2000114) | 2.32384600 |
| 82 | Golgi to endosome transport (GO:0006895) | 2.32382349 |
| 83 | establishment of protein localization to vacuole (GO:0072666) | 2.31222322 |
| 84 | protein targeting to vacuole (GO:0006623) | 2.31222322 |
| 85 | protein targeting to lysosome (GO:0006622) | 2.31222322 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.30204936 |
| 87 | necrotic cell death (GO:0070265) | 2.28740215 |
| 88 | thymic T cell selection (GO:0045061) | 2.26440731 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.26179374 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25807294 |
| 91 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.25606923 |
| 92 | T cell mediated immunity (GO:0002456) | 2.25233771 |
| 93 | detection of other organism (GO:0098543) | 2.25187735 |
| 94 | regulation of ARF protein signal transduction (GO:0032012) | 2.24667712 |
| 95 | early endosome to late endosome transport (GO:0045022) | 2.24516534 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.23669887 |
| 97 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.23514954 |
| 98 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.23442240 |
| 99 | neutrophil mediated immunity (GO:0002446) | 2.23251420 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.22389974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.87917050 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.23924172 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.02242094 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92795046 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77263820 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75227823 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48657599 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.47165626 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.46336465 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.42695397 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26928617 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25223972 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19125559 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17833656 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14765680 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12098201 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10936679 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09224617 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.97638174 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83699444 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77992266 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75256759 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70494573 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69874639 |
| 25 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.69134765 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68819611 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.68708264 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67556508 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66916366 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.66090121 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63487501 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.62001405 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58177896 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.51261722 |
| 35 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51060230 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.51034262 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49884273 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48641562 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.47112484 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46164141 |
| 41 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44699380 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44022703 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43175127 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39613280 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36040930 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34600359 |
| 47 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.30956836 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28925259 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28625508 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26035951 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25508672 |
| 52 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.24049713 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23870587 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23490277 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21578437 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21123283 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19665807 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18679726 |
| 59 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18373239 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18305497 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18232779 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17627945 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15715538 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14787947 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14335903 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12092971 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11696539 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11377336 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11005686 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11005686 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10358743 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09210584 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08662176 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08471740 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07663921 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07061383 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07042321 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.05845868 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05184954 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05184954 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05147839 |
| 82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03823261 |
| 83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02896613 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02450229 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02169276 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01866430 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01518129 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01330329 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00518241 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00418664 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00351552 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99564140 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99091246 |
| 94 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98050181 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97918716 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 0.97826945 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97796094 |
| 98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97286237 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97201690 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96292018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 4.51654873 |
| 2 | MP0002166_altered_tumor_susceptibility | 2.98089587 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.90616918 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.83442286 |
| 5 | MP0008057_abnormal_DNA_replication | 2.82127616 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.74732381 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.46802005 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 2.45233869 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.34927289 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.34246349 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.26535547 |
| 12 | MP0003303_peritoneal_inflammation | 2.07882978 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.06863809 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.06291141 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 1.96213169 |
| 16 | MP0003724_increased_susceptibility_to | 1.94561522 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 1.93903833 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.90178718 |
| 19 | MP0002006_tumorigenesis | 1.82499776 |
| 20 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81129788 |
| 21 | MP0005451_abnormal_body_composition | 1.80866749 |
| 22 | MP0004381_abnormal_hair_follicle | 1.80108645 |
| 23 | MP0010678_abnormal_skin_adnexa | 1.78750706 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.78361325 |
| 25 | MP0001800_abnormal_humoral_immune | 1.75318178 |
| 26 | MP0003868_abnormal_feces_composition | 1.70206918 |
| 27 | MP0008260_abnormal_autophagy | 1.69350712 |
| 28 | MP0000383_abnormal_hair_follicle | 1.66760524 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.66321381 |
| 30 | MP0003866_abnormal_defecation | 1.62638616 |
| 31 | MP0004947_skin_inflammation | 1.57708257 |
| 32 | MP0002398_abnormal_bone_marrow | 1.46793333 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.44161414 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.43426612 |
| 35 | MP0000685_abnormal_immune_system | 1.41894042 |
| 36 | MP0003091_abnormal_cell_migration | 1.40627214 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.39074000 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.32699721 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.31008445 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.30636328 |
| 41 | MP0004043_abnormal_pH_regulation | 1.29753334 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.29751341 |
| 43 | MP0002722_abnormal_immune_system | 1.29447585 |
| 44 | MP0001851_eye_inflammation | 1.29257609 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.29232402 |
| 46 | MP0001819_abnormal_immune_cell | 1.28887612 |
| 47 | MP0005409_darkened_coat_color | 1.28805095 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.28678393 |
| 49 | MP0002723_abnormal_immune_serum | 1.28133200 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.27830859 |
| 51 | MP0002405_respiratory_system_inflammati | 1.25383350 |
| 52 | MP0005671_abnormal_response_to | 1.23800882 |
| 53 | MP0001790_abnormal_immune_system | 1.18343466 |
| 54 | MP0005387_immune_system_phenotype | 1.18343466 |
| 55 | MP0003436_decreased_susceptibility_to | 1.17621742 |
| 56 | MP0005025_abnormal_response_to | 1.16912000 |
| 57 | MP0000716_abnormal_immune_system | 1.16645035 |
| 58 | MP0005310_abnormal_salivary_gland | 1.16441664 |
| 59 | MP0002419_abnormal_innate_immunity | 1.14922659 |
| 60 | MP0001915_intracranial_hemorrhage | 1.10386995 |
| 61 | MP0003252_abnormal_bile_duct | 1.09763090 |
| 62 | MP0003690_abnormal_glial_cell | 1.07583409 |
| 63 | MP0005408_hypopigmentation | 1.07370934 |
| 64 | MP0010307_abnormal_tumor_latency | 1.07216411 |
| 65 | MP0000377_abnormal_hair_follicle | 1.06173438 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.06056934 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.05675459 |
| 68 | MP0005365_abnormal_bile_salt | 1.00832757 |
| 69 | MP0003787_abnormal_imprinting | 0.99532051 |
| 70 | MP0005621_abnormal_cell_physiology | 0.98543198 |
| 71 | MP0000609_abnormal_liver_physiology | 0.96655780 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.95433746 |
| 73 | MP0002971_abnormal_brown_adipose | 0.95281694 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.94906189 |
| 75 | MP0002429_abnormal_blood_cell | 0.93836234 |
| 76 | MP0009115_abnormal_fat_cell | 0.93719808 |
| 77 | MP0002086_abnormal_extraembryonic_tissu | 0.92547991 |
| 78 | MP0000858_altered_metastatic_potential | 0.92522108 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.91899266 |
| 80 | MP0004883_abnormal_blood_vessel | 0.91370278 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.91043624 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.90133749 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.88050789 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.84836831 |
| 85 | MP0002132_abnormal_respiratory_system | 0.84798639 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.83938446 |
| 87 | MP0002796_impaired_skin_barrier | 0.83576154 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.83295016 |
| 89 | MP0003828_pulmonary_edema | 0.79667872 |
| 90 | MP0000427_abnormal_hair_cycle | 0.74666701 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 0.74515305 |
| 92 | MP0009785_altered_susceptibility_to | 0.73279417 |
| 93 | MP0009763_increased_sensitivity_to | 0.72977928 |
| 94 | MP0003943_abnormal_hepatobiliary_system | 0.72971163 |
| 95 | MP0005384_cellular_phenotype | 0.70645317 |
| 96 | MP0000371_diluted_coat_color | 0.70432373 |
| 97 | MP0001873_stomach_inflammation | 0.69642215 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 0.66410269 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.66240811 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.66045636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.71288059 |
| 2 | Thyroid carcinoma (HP:0002890) | 3.13313214 |
| 3 | T lymphocytopenia (HP:0005403) | 3.12284619 |
| 4 | Eczematoid dermatitis (HP:0000976) | 2.89812995 |
| 5 | Subacute progressive viral hepatitis (HP:0006572) | 2.86037909 |
| 6 | Abnormality of T cell number (HP:0011839) | 2.84693691 |
| 7 | Recurrent bronchitis (HP:0002837) | 2.82109166 |
| 8 | Insidious onset (HP:0003587) | 2.73610310 |
| 9 | Termporal pattern (HP:0011008) | 2.73610310 |
| 10 | Curly hair (HP:0002212) | 2.73254815 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.72688083 |
| 12 | Rhinitis (HP:0012384) | 2.55895088 |
| 13 | Heterotopia (HP:0002282) | 2.55349352 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.48481180 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 2.48481180 |
| 16 | Bronchiectasis (HP:0002110) | 2.46431869 |
| 17 | Absent frontal sinuses (HP:0002688) | 2.43671981 |
| 18 | Flat acetabular roof (HP:0003180) | 2.38673271 |
| 19 | Coarse hair (HP:0002208) | 2.38507952 |
| 20 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.37482901 |
| 21 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.37482901 |
| 22 | Recurrent sinusitis (HP:0011108) | 2.37119439 |
| 23 | Bronchitis (HP:0012387) | 2.31463619 |
| 24 | Viral hepatitis (HP:0006562) | 2.30433732 |
| 25 | Abnormality of the fingertips (HP:0001211) | 2.30069038 |
| 26 | Abnormal ciliary motility (HP:0012262) | 2.26817946 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.26521203 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.26364623 |
| 29 | Recurrent viral infections (HP:0004429) | 2.24823108 |
| 30 | Hypoplasia of the thymus (HP:0000778) | 2.23448941 |
| 31 | Chronic diarrhea (HP:0002028) | 2.21632494 |
| 32 | Colitis (HP:0002583) | 2.19843602 |
| 33 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.17425534 |
| 34 | Deep philtrum (HP:0002002) | 2.15484453 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.13461230 |
| 36 | Gingival bleeding (HP:0000225) | 2.10824753 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.10239925 |
| 38 | Asymmetry of the thorax (HP:0001555) | 2.09555385 |
| 39 | Chronic otitis media (HP:0000389) | 2.04979165 |
| 40 | Syringomyelia (HP:0003396) | 2.04909452 |
| 41 | Spinal cord lesions (HP:0100561) | 2.04909452 |
| 42 | Menstrual irregularities (HP:0000858) | 2.03060869 |
| 43 | Macroorchidism (HP:0000053) | 2.01590595 |
| 44 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.99952404 |
| 45 | Recurrent abscess formation (HP:0002722) | 1.99748945 |
| 46 | Vertebral arch anomaly (HP:0008438) | 1.98056516 |
| 47 | Periodontitis (HP:0000704) | 1.97986136 |
| 48 | Nasal polyposis (HP:0100582) | 1.96915771 |
| 49 | Recurrent otitis media (HP:0000403) | 1.96255992 |
| 50 | Thickened calvaria (HP:0002684) | 1.95938393 |
| 51 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92926330 |
| 52 | Overlapping toe (HP:0001845) | 1.92777349 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92748189 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 1.92454684 |
| 55 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.91546305 |
| 56 | Acute myeloid leukemia (HP:0004808) | 1.89341785 |
| 57 | Acanthocytosis (HP:0001927) | 1.89157547 |
| 58 | Prolonged bleeding time (HP:0003010) | 1.88527117 |
| 59 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.87163577 |
| 60 | Gastrointestinal carcinoma (HP:0002672) | 1.87163577 |
| 61 | Ankyloglossia (HP:0010296) | 1.87141998 |
| 62 | Gingivitis (HP:0000230) | 1.86523918 |
| 63 | Inflammation of the large intestine (HP:0002037) | 1.86323363 |
| 64 | Osteomyelitis (HP:0002754) | 1.84821927 |
| 65 | Truncal obesity (HP:0001956) | 1.84136756 |
| 66 | Hip dysplasia (HP:0001385) | 1.83972424 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 1.83713804 |
| 68 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.83401441 |
| 69 | Bladder carcinoma (HP:0002862) | 1.83353551 |
| 70 | Bladder neoplasm (HP:0009725) | 1.83353551 |
| 71 | Biliary tract neoplasm (HP:0100574) | 1.82300221 |
| 72 | Medulloblastoma (HP:0002885) | 1.81600757 |
| 73 | Scanning speech (HP:0002168) | 1.81410747 |
| 74 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80820831 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80604183 |
| 76 | Cystic hygroma (HP:0000476) | 1.80121081 |
| 77 | Granulocytopenia (HP:0001913) | 1.79841660 |
| 78 | Eosinophilia (HP:0001880) | 1.75698414 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74382031 |
| 80 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74257927 |
| 81 | Cellulitis (HP:0100658) | 1.73613656 |
| 82 | Prominent nose (HP:0000448) | 1.73508701 |
| 83 | Broad palm (HP:0001169) | 1.71627020 |
| 84 | Blue irides (HP:0000635) | 1.70033922 |
| 85 | Chronic sinusitis (HP:0011109) | 1.69392083 |
| 86 | Micronodular cirrhosis (HP:0001413) | 1.69329905 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 1.68136082 |
| 88 | Meningitis (HP:0001287) | 1.67411953 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 1.65450145 |
| 90 | Tubulointerstitial nephritis (HP:0001970) | 1.64631153 |
| 91 | Abnormal platelet volume (HP:0011876) | 1.64610074 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 1.64472907 |
| 93 | Abnormal foot bone ossification (HP:0010675) | 1.63572851 |
| 94 | Recurrent fungal infections (HP:0002841) | 1.63330551 |
| 95 | Fair hair (HP:0002286) | 1.62336361 |
| 96 | Germ cell neoplasia (HP:0100728) | 1.62212735 |
| 97 | Leiomyosarcoma (HP:0100243) | 1.61283821 |
| 98 | Uterine leiomyosarcoma (HP:0002891) | 1.61283821 |
| 99 | Tapered finger (HP:0001182) | 1.61280696 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.60391505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.09405792 |
| 2 | BCR | 2.67361348 |
| 3 | BRD4 | 2.41454028 |
| 4 | FGFR3 | 2.40810228 |
| 5 | SCYL2 | 2.33590849 |
| 6 | MAP3K14 | 2.31287203 |
| 7 | EPHA3 | 2.01823582 |
| 8 | FGFR4 | 1.96675231 |
| 9 | EEF2K | 1.96311963 |
| 10 | SIK3 | 1.92663697 |
| 11 | MAP3K10 | 1.88579002 |
| 12 | ERBB3 | 1.87745519 |
| 13 | PRPF4B | 1.86085248 |
| 14 | BMPR2 | 1.81311159 |
| 15 | RIPK4 | 1.80448263 |
| 16 | PKN2 | 1.76662435 |
| 17 | MAP3K2 | 1.71613692 |
| 18 | CDK6 | 1.65599502 |
| 19 | MAP3K4 | 1.59073099 |
| 20 | LATS1 | 1.58424652 |
| 21 | JAK1 | 1.47593317 |
| 22 | AKT3 | 1.47580855 |
| 23 | NEK6 | 1.46647761 |
| 24 | YES1 | 1.45735925 |
| 25 | SIK2 | 1.36725732 |
| 26 | EIF2AK3 | 1.29425695 |
| 27 | BTK | 1.28401331 |
| 28 | CSK | 1.23060000 |
| 29 | SGK2 | 1.21719043 |
| 30 | TAOK3 | 1.20734241 |
| 31 | MAP4K1 | 1.19679963 |
| 32 | RIPK1 | 1.18705766 |
| 33 | RET | 1.18333035 |
| 34 | ACVR1B | 1.17130111 |
| 35 | TYK2 | 1.14339869 |
| 36 | SGK3 | 1.13965407 |
| 37 | MARK2 | 1.13943039 |
| 38 | CAMKK2 | 1.12760104 |
| 39 | RPS6KA4 | 1.12616133 |
| 40 | KSR1 | 1.10393985 |
| 41 | NEK9 | 1.08154673 |
| 42 | TRPM7 | 1.04425034 |
| 43 | TRIB3 | 1.02215299 |
| 44 | JAK2 | 1.01381480 |
| 45 | MAP3K6 | 1.00847819 |
| 46 | EIF2AK1 | 1.00216512 |
| 47 | NLK | 0.99808715 |
| 48 | WNK1 | 0.99486302 |
| 49 | FES | 0.94258583 |
| 50 | ICK | 0.93966727 |
| 51 | DYRK1B | 0.93786057 |
| 52 | PDGFRA | 0.93342212 |
| 53 | SRPK1 | 0.90440225 |
| 54 | HCK | 0.89345574 |
| 55 | KSR2 | 0.86028959 |
| 56 | STK24 | 0.85658725 |
| 57 | TEC | 0.84758687 |
| 58 | BLK | 0.84066913 |
| 59 | JAK3 | 0.83269523 |
| 60 | IKBKE | 0.83197931 |
| 61 | MAPK11 | 0.82874587 |
| 62 | GRK6 | 0.78964336 |
| 63 | EPHB1 | 0.78869858 |
| 64 | TXK | 0.78385125 |
| 65 | LCK | 0.77152987 |
| 66 | ITK | 0.76499313 |
| 67 | MAP2K4 | 0.72414494 |
| 68 | SYK | 0.71603954 |
| 69 | PDGFRB | 0.71558748 |
| 70 | RPS6KB1 | 0.71248500 |
| 71 | SGK494 | 0.70127129 |
| 72 | SGK223 | 0.70127129 |
| 73 | IRAK4 | 0.69705799 |
| 74 | MAP3K13 | 0.68082428 |
| 75 | MST1R | 0.67341292 |
| 76 | IRAK1 | 0.66545278 |
| 77 | CSF1R | 0.65827536 |
| 78 | MAP3K1 | 0.64518890 |
| 79 | DYRK3 | 0.63973314 |
| 80 | STK3 | 0.60920685 |
| 81 | MAP3K7 | 0.60800177 |
| 82 | RPS6KB2 | 0.60671285 |
| 83 | LYN | 0.60463866 |
| 84 | FGR | 0.60456177 |
| 85 | ERBB2 | 0.59415504 |
| 86 | CLK1 | 0.57439375 |
| 87 | PDK1 | 0.57339574 |
| 88 | ZAP70 | 0.57069172 |
| 89 | FER | 0.55595237 |
| 90 | MELK | 0.54959203 |
| 91 | CDK4 | 0.54649825 |
| 92 | MAP2K7 | 0.54355185 |
| 93 | BRSK2 | 0.50964142 |
| 94 | SGK1 | 0.49052222 |
| 95 | RAF1 | 0.47655427 |
| 96 | MAPK10 | 0.45164957 |
| 97 | MAPK7 | 0.44433534 |
| 98 | CHUK | 0.42833808 |
| 99 | TAOK1 | 0.42204761 |
| 100 | TGFBR2 | 0.40181084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06187566 |
| 2 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.88712649 |
| 3 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.86280113 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71246627 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62850587 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61246544 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52977001 |
| 8 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.51550503 |
| 9 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.50349624 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50059129 |
| 11 | Endometrial cancer_Homo sapiens_hsa05213 | 1.44079064 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.42097353 |
| 13 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36567277 |
| 14 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35579062 |
| 15 | Colorectal cancer_Homo sapiens_hsa05210 | 1.35261463 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.32719994 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30127260 |
| 18 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.29278353 |
| 19 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.25938187 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24596572 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22754103 |
| 22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21948514 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.21863374 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21111980 |
| 25 | Hepatitis C_Homo sapiens_hsa05160 | 1.19835287 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17552798 |
| 27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15840873 |
| 28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12120029 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10055673 |
| 30 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.10046385 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09347781 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.06719944 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06676127 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.06344121 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05118161 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04595029 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.03457388 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00376594 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00261609 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99653195 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99079915 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98989240 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 0.98751451 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98370107 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97792093 |
| 46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94613226 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.92390793 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.92371922 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91977951 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.90521069 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90417725 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88767081 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88752469 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.87988478 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86665277 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84198989 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81187473 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80486613 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80443894 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80211532 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79101343 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78603097 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77418157 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76363377 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75426719 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74149232 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72885098 |
| 68 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72383271 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72113437 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.72001043 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.70327860 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70274898 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70037340 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69893421 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69487160 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66746878 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65892078 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64314492 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64273184 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63927468 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.62496907 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62069807 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62002318 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.61123059 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61015738 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59577263 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57268548 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57068382 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55812092 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55022790 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54720885 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53846721 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.53451520 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.52895581 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.50809939 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49926060 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49845916 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.46799580 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46639295 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45437491 |

